{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/jaundice-in-adults/background-information/causes/","result":{"pageContext":{"chapter":{"id":"96c3c504-5932-5b65-83dc-1c20c7848e0a","slug":"causes","fullItemName":"Causes","depth":2,"htmlHeader":"<!-- begin field 932e98f5-d0bb-48f2-8af1-3567e874ce44 --><h2>Causes</h2><!-- end field 932e98f5-d0bb-48f2-8af1-3567e874ce44 -->","summary":"","htmlStringContent":"<!-- begin item ecb19af2-7bb7-4b89-98fa-b8498e2a1398 --><!-- begin field 80f3b560-130a-41d6-8b82-17ce148d0f28 --><ul><li>The categories of pre-hepatic, intra-hepatic, and post-hepatic (obstructive) jaundice are not mutually exclusive and more than one mechanism leading to jaundice can be present at one time.</li><li>Some conditions are rare causes of jaundice (such as Crigler-Najjar syndrome) while others (such as gallstone disease, alcohol misuse, and malignancy) are much more common in the UK.<ul><li><strong>Causes of pre-hepatic jaundice include:</strong><ul><li><a class=\"topic-reference internal-reference\" href=\"/topics/jaundice-in-adults/background-information/causes/#haemolytic-anaemia\">Haemolytic anaemias</a>.</li><li><a class=\"topic-reference internal-reference\" href=\"/topics/jaundice-in-adults/background-information/causes/#drugs\">Drugs</a>.</li><li><a class=\"topic-reference internal-reference\" href=\"/topics/jaundice-in-adults/background-information/causes/#gilberts-syndrome\">Gilbert's syndrome</a>.</li><li><a class=\"topic-reference internal-reference\" href=\"/topics/jaundice-in-adults/background-information/causes/#crigler-najjar-syndrome\">Crigler-Najjar syndrome</a>.</li></ul></li><li><strong>Causes of intra-hepatic jaundice include:</strong><ul><li><a class=\"topic-reference internal-reference\" href=\"/topics/jaundice-in-adults/background-information/causes/#viral-infection\">Viral infection</a>.</li><li><a class=\"topic-reference internal-reference\" href=\"/topics/jaundice-in-adults/background-information/causes/#alcohol\">Alcohol</a>.</li><li><a class=\"topic-reference internal-reference\" href=\"/topics/jaundice-in-adults/background-information/causes/#non-alcoholic-fatty-liver-disease\">Non-alcoholic fatty liver disease (NAFLD)</a>.</li><li><a class=\"topic-reference internal-reference\" href=\"/topics/jaundice-in-adults/background-information/causes/#autoimmune-liver-disorders\">Autoimmune liver disorders</a>.</li><li><a class=\"topic-reference internal-reference\" href=\"/topics/jaundice-in-adults/background-information/causes/#metabolic-causes\">Metabolic causes of intra-hepatic jaundice</a>.</li><li><a class=\"topic-reference internal-reference\" href=\"/topics/jaundice-in-adults/background-information/causes/#drugs\">Drugs</a>.</li><li><a class=\"topic-reference internal-reference\" href=\"/topics/jaundice-in-adults/background-information/causes/#malignancy-of-the-biliary-system\">Malignancy of the biliary system</a>.</li></ul></li><li><strong>Causes of post-hepatic or obstructive jaundice include:</strong><ul><li><a class=\"topic-reference internal-reference\" href=\"/topics/jaundice-in-adults/background-information/causes/#gallstones\">Gallstones</a>.</li><li><a class=\"topic-reference internal-reference\" href=\"/topics/jaundice-in-adults/background-information/causes/#surgical-strictures\">Surgical strictures</a>.</li><li><a class=\"topic-reference internal-reference\" href=\"/topics/jaundice-in-adults/background-information/causes/#extra-hepatic-malignancy\">Extra-hepatic malignancy</a>.</li><li><a class=\"topic-reference internal-reference\" href=\"/topics/jaundice-in-adults/background-information/causes/#pancreatitis\">Pancreatitis</a>.</li><li><a class=\"topic-reference internal-reference\" href=\"/topics/jaundice-in-adults/background-information/causes/#parasitic-infection\">Parasitic infection</a>.</li></ul></li></ul></li><li>Pseudojaundice can occur with excessive ingestion of beta-carotene rich foods such as carrot or squash — in this case serum bilirubin is not elevated and scleral icterus does not occur.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">Roche, 2004</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">Warrell, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">Simon, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">Fargo, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">BMJ Best Practice, 2019</a>]</p><!-- end field 80f3b560-130a-41d6-8b82-17ce148d0f28 --><!-- end item ecb19af2-7bb7-4b89-98fa-b8498e2a1398 -->","topic":{"id":"517d5301-7d5a-50be-aa9f-5b5f2e5a1ac2","topicId":"2f2490fa-8fe7-4e82-937d-16d0c246af28","topicName":"Jaundice in adults","slug":"jaundice-in-adults","lastRevised":"Last revised in November 2020","chapters":[{"id":"a41fa4d5-aaf9-558f-a200-a15d9ae24b73","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"4b100f17-858f-5860-b737-8358b8ad4e40","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"b3211749-3c3a-5d89-863c-5c9a8bac1051","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"7086a372-81e6-56a3-ab69-cae90c352870","slug":"changes","fullItemName":"Changes"},{"id":"75696af8-b6b9-5e35-8d4b-bb9797a7e30e","slug":"update","fullItemName":"Update"}]},{"id":"1f3fdaa2-4042-53bd-bfa1-b9b817765712","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"5dc38689-6ca3-5f08-b82e-a0901a0eb94d","slug":"goals","fullItemName":"Goals"},{"id":"fbabc528-91c0-58ad-85e9-34373cbf2649","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"a478864c-049f-5a95-912c-da77a6409724","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"aaa0268c-73ff-5ed6-8f75-90eb116dbf89","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"e58dfa37-a954-5f41-bcf3-cd2264253789","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"b1891943-d6c0-5f2f-9a9f-f3204be1ac47","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"08826cc0-037c-5bac-b439-8f79488aed70","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"e132a2db-c13f-58ac-9020-f17d9bc809e7","slug":"definition","fullItemName":"Definition"},{"id":"de318bf6-2016-5a90-939b-19f1d22a779c","slug":"pathophysiology","fullItemName":"Pathophysiology"},{"id":"96c3c504-5932-5b65-83dc-1c20c7848e0a","slug":"causes","fullItemName":"Causes"},{"id":"d76d70a4-a469-5749-a699-59521eb1ead1","slug":"prevalence","fullItemName":"Prevalence"},{"id":"f47fa662-051d-5307-ada7-99b2ada242f4","slug":"risk-factors","fullItemName":"Risk factors"}]},{"id":"7cabc727-d00f-55b2-8a6f-4707af4d7157","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"7838d032-4715-595c-9029-f183e606749b","slug":"assessing-a-person-with-jaundice","fullItemName":"Assessing a person with jaundice"}]},{"id":"48e2dd52-27f9-5631-b987-589ad6f71ae3","fullItemName":"Management","slug":"management","subChapters":[{"id":"f08a38f4-c513-5356-8b70-7562aa88ee0c","slug":"management-of-jaundice-in-adults","fullItemName":"Scenario: Management of jaundice in adults"}]},{"id":"57dfb6aa-c306-5c03-afe4-c2bdd0a93684","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"a665f23d-c451-5c74-9056-8fbd50b70927","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"434744ca-a9a5-5aa1-b361-377e83f269ad","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"ada4134b-bf53-5890-bb39-37e20d7c8c07","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"79937cb7-9330-5001-82f6-a0d844ee98d0","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"730388da-4c3c-55cc-93ad-00439e2a8ee7","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"02a6ff74-c849-5cdf-afc5-046d03ab99d1","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"94689803-b200-5797-a77d-6915ede2f3b1","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"08826cc0-037c-5bac-b439-8f79488aed70","slug":"background-information","fullItemName":"Background information"},"subChapters":[{"id":"8621fdf4-c5f7-57ac-9cd2-7cb3124f46da","slug":"haemolytic-anaemia","fullItemName":"Haemolytic anaemia","depth":3,"htmlHeader":"<!-- begin field 54aa940b-d57c-416d-8f5a-58ac48937633 --><h3>Haemolytic anaemias</h3><!-- end field 54aa940b-d57c-416d-8f5a-58ac48937633 -->","summary":null,"htmlStringContent":"<!-- begin item fe74d284-51c2-40c6-8d95-d4c2501ff6d1 --><!-- begin field 8d38761c-fe7d-420a-aae7-171085afd6d9 --><ul><li>Haemolytic anaemias result from increased haemolysis of abnormal red blood cells due to conditions such as:<ul><li><strong>Homozygous sickle cell disease</strong> and <strong>thalassemia major </strong>which are inherited disorders that produce defects in haemoglobin structure. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/sickle-cell-disease/\">Sickle cell disease</a> for further information.</li><li><strong>Hereditary spherocytosis</strong> which causes membrane abnormalities.</li><li><strong>Glucose-6-phosphate dehydrogenase deficiency</strong> which is due to enzyme abnormalities.</li><li><strong>Vitamin B12 deficiency</strong> (pernicious anaemia) which can cause ineffective erythropoiesis of the bone marrow leading to mildly elevated bilirubin levels — see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/anaemia-b12-folate-deficiency/\">Anaemia - B12 and folate deficiency</a> for further information.</li><li><strong>Autoimmune disorders</strong> including systemic lupus erythematosus which cause anaemia of chronic disease but may also impair erythropoietin function.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">Roche, 2004</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">Giannouli, 2006</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">Warrell, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">BMJ Best Practice, 2019</a>]</p><!-- end field 8d38761c-fe7d-420a-aae7-171085afd6d9 --><!-- end item fe74d284-51c2-40c6-8d95-d4c2501ff6d1 -->","subChapters":[]},{"id":"b6a5f612-7d88-5049-836b-846a5acedd8c","slug":"drugs","fullItemName":"Drugs","depth":3,"htmlHeader":"<!-- begin field 9ec9745c-ad8d-455c-b76d-bca7bfc7d14a --><h3>Drugs</h3><!-- end field 9ec9745c-ad8d-455c-b76d-bca7bfc7d14a -->","summary":null,"htmlStringContent":"<!-- begin item f4f41aaf-266b-453b-8435-d526314cb353 --><!-- begin field 609f4339-f784-4a6a-b546-7238aef584dd --><ul><li>Antibiotics and anti-epileptics are the most commonly reported drugs causing drug-induced liver injury (DILI).</li><li>Usually DILI occurs within 6 months of starting a new drug, but this may vary widely.</li><li>Drugs can cause jaundice through:<ul><li>Haemolysis of red blood cells (for example, methyldopa, and sulphasalazine).</li><li>Hepatitis (for example, paracetamol overdose, pyrazinamide, rifampicin, and isoniazid).</li><li>Cholestasis (for example, co-amoxiclav, flucloxacillin, oral contraceptives, hormone replacement therapy, chlorpromazine, and corticosteroids).</li><li>Hepatic idiosyncratic reactions (for example, aspirin, nonsteroidal anti-inflammatory drugs [NSAIDs], amiodarone, sodium valproate, and minocycline).</li></ul></li><li>Non-prescribed drugs, such as herbal medicines, or dietary supplements, such as green tea extract, anabolic corticosteroids, and flavocoxid, have been documented as causing DILI and can lead to acute liver failure.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">Beckingham, 2001</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">Ryder, 2001</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">Roche, 2004</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">Chalasani, 2014</a>]</p><!-- end field 609f4339-f784-4a6a-b546-7238aef584dd --><!-- end item f4f41aaf-266b-453b-8435-d526314cb353 -->","subChapters":[]},{"id":"72c7bb9e-eecb-5141-a64f-8c1f1871cdb0","slug":"gilberts-syndrome","fullItemName":"Gilbert's syndrome","depth":3,"htmlHeader":"<!-- begin field 946d02fa-1546-4fc4-a77d-e7f09e7c8b6c --><h3>Gilbert's syndrome</h3><!-- end field 946d02fa-1546-4fc4-a77d-e7f09e7c8b6c -->","summary":null,"htmlStringContent":"<!-- begin item eab249a2-8680-409e-b25b-fc4807e0a74a --><!-- begin field 16235a21-9662-4eec-be2e-af8fff622b71 --><ul><li>At least 3% of the adult population have Gilbert’s syndrome.</li><li>It is an inherited metabolic disorder that causes excess unconjugated bilirubin due to defective conjugating enzymes in the hepatocytes.</li><li>Typically, it presents as an incidental finding on blood tests, with slightly raised serum bilirubin levels, while other routine liver function tests and reticulocyte count remain within normal limits.</li><li>Plasma bilirubin concentrations can rise in people with Gilbert’s syndrome during intercurrent illness, periods of stress, when dehydrated or fasting, or during menstruation. Frank jaundice may occur.</li><li>No treatment is required.</li><li>See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/gilberts-syndrome/\">Gilbert's syndrome</a> for further information.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">Beckingham, 2001</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">Roche, 2004</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">Warrell, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">BMJ Best Practice, 2019</a>]</p><!-- end field 16235a21-9662-4eec-be2e-af8fff622b71 --><!-- end item eab249a2-8680-409e-b25b-fc4807e0a74a -->","subChapters":[]},{"id":"a6485d2d-277b-52df-9da4-59e2b57d941e","slug":"crigler-najjar-syndrome","fullItemName":"Crigler-Najjar syndrome","depth":3,"htmlHeader":"<!-- begin field 42d9c17f-4d04-43c1-a3c3-47a4c45f303b --><h3>Crigler-Najjar syndrome</h3><!-- end field 42d9c17f-4d04-43c1-a3c3-47a4c45f303b -->","summary":null,"htmlStringContent":"<!-- begin item c87f5cc2-d241-4844-9b21-3108fece8401 --><!-- begin field 2b682e6d-7249-4afe-8f8a-97f998c24059 --><ul><li>Crigler-Najjar syndrome is a rare inherited disorder causing defects in the hepatic bilirubin conjugating enzyme leading to unconjugated hyperbilirubinaemia.<ul><li><strong>Type 1 Crigler-Najjar syndrome</strong> presents in neonates with progressive jaundice in the first few days of life. If untreated it leads to bilirubin encephalopathy (kernicterus) and death.</li><li><strong>Type 2 Crigler-Najjar syndrome</strong> is less severe and brain damage does not occur.</li></ul></li><li>Bilirubin encephalopathy may occur in later life with intercurrent infection, ingestion of drugs that displace unconjugated bilirubin from albumin (sulphonamides, salicylates, or penicillin), or stress.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">Warrell, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">Fargo, 2017</a>]</p><!-- end field 2b682e6d-7249-4afe-8f8a-97f998c24059 --><!-- end item c87f5cc2-d241-4844-9b21-3108fece8401 -->","subChapters":[]},{"id":"108000cb-6db4-53f2-95f1-7db54f60d483","slug":"viral-infection","fullItemName":"Viral infection","depth":3,"htmlHeader":"<!-- begin field 72db6942-223d-4264-b14f-30194325ce73 --><h3>Viral infection</h3><!-- end field 72db6942-223d-4264-b14f-30194325ce73 -->","summary":null,"htmlStringContent":"<!-- begin item a21b5fff-0fd7-4f6d-9c62-56480e39810a --><!-- begin field a1a2e128-4cc2-4a03-9e64-b919559d2653 --><ul><li><strong>Viral hepatitis (hepatitis A, B, C, D, and E)</strong> can cause jaundice through intra-hepatic inflammation leading to disruption in the transport of conjugated bilirubin.<ul><li>Hepatitis A is usually self-limiting and presents with acute jaundice — see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/hepatitis-a/\">Hepatitis A</a> for further information.</li><li>Hepatitis B and C infections may not cause jaundice in the initial phase of infection but can lead to progressive jaundice when chronic infection leads to cirrhosis — see the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/hepatitis-b/\">Hepatitis B</a> and <a class=\"topic-reference external-reference\" href=\"/topics/hepatitis-c/\">Hepatitis C</a> for further information.</li><li>Hepatitis D only causes clinically significant disease when co-infection with hepatitis B is present.</li><li>Hepatitis E occurs worldwide, particularly in regions where sanitation is poor. It is spread predominantly by the faeco-oral route. It usually produces a mild disease but some groups such as pregnant women and the immunocompromised are at risk of more severe disease. For information on diagnosis and management, please see the PHE document <a href=\"https://www.gov.uk/government/publications/hepatitis-e-symptoms-transmission-prevention-treatment/hepatitis-e-symptoms-transmission-treatment-and-prevention\" data-hyperlink-id=\"252ae297-a2fc-4aac-9926-ac7500f3c592\">Hepatitis E: symptoms, transmission, treatment and prevention</a>.</li></ul></li><li><strong>Epstein-Barr virus</strong> infection occasionally causes transient hepatitis and jaundice — see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/glandular-fever-infectious-mononucleosis/\">Glandular fever (infectious mononucleosis)</a> for further information.</li><li><strong>HIV infection</strong> can cause jaundice through extra-hepatic obstruction due to AIDS cholangiopathy — see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/hiv-infection-aids/\">HIV infection and AIDS</a> for further information.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">Roche, 2004</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">PHE, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">PHE, 2020</a>]</p><!-- end field a1a2e128-4cc2-4a03-9e64-b919559d2653 --><!-- end item a21b5fff-0fd7-4f6d-9c62-56480e39810a -->","subChapters":[]},{"id":"8c449f79-d3be-5641-84eb-7a2498b24b53","slug":"alcohol","fullItemName":"Alcohol","depth":3,"htmlHeader":"<!-- begin field af97612d-f690-4937-9fbc-7f051b822857 --><h3>Alcohol</h3><!-- end field af97612d-f690-4937-9fbc-7f051b822857 -->","summary":null,"htmlStringContent":"<!-- begin item 4a94d226-ca69-4c6f-97b1-b47bf9ff820f --><!-- begin field adfc7e91-7ddc-45fe-8ec7-971ddd5f066f --><ul><li>Alcohol-related liver disease is a major cause of morbidity and mortality in Europe and the standardized mortality rate from alcohol-related liver disease in some areas is as high as 47 per 100,000 men.</li><li>In England, data collected from 2015 to 2017 showed that standardized mortality rates for premature alcoholic liver disease are significantly higher in males (11.9 per 100,000 population aged under 75 years) than in females (6.1 per 100,000 population aged under 75 years).</li><li>Jaundice can occur due to:<br><ul><li>Alcoholic hepatitis. This typically presents with jaundice and liver failure in a person who has a history of chronic alcohol misuse.</li><li>Disruption of bile uptake and secretion resulting in cholestasis.</li><li>Development of fatty liver (steatosis) and cirrhosis with jaundice from chronic alcohol misuse.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">Roche, 2004</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">Lucey, 2009</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">Blachier, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">Fargo, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">PHE, 2018</a>]</p><!-- end field adfc7e91-7ddc-45fe-8ec7-971ddd5f066f --><!-- end item 4a94d226-ca69-4c6f-97b1-b47bf9ff820f -->","subChapters":[]},{"id":"4f123230-645b-519d-b573-a1a79b5c9308","slug":"non-alcoholic-fatty-liver-disease","fullItemName":"Non-alcoholic fatty liver disease","depth":3,"htmlHeader":"<!-- begin field 5fdb79c4-eec4-48fa-a020-41225008d7b0 --><h3>Non-alcoholic fatty liver disease (NAFLD)</h3><!-- end field 5fdb79c4-eec4-48fa-a020-41225008d7b0 -->","summary":null,"htmlStringContent":"<!-- begin item 36bab86a-e0b4-4d47-ad90-4f2be2e8025d --><!-- begin field 5360db4d-0f54-4fc0-9f24-55a1b7143a95 --><ul><li>Non-alcoholic fatty liver disease refers to excessive fat accumulation (steatosis) in the hepatocytes.</li><li>Steatosis can be associated with hepatocellular injury, inflammation, and may progress to advanced liver fibrosis and cirrhosis.</li><li>The exact cause is not fully understood but it has been linked to insulin resistance, obesity, and the metabolic syndrome.<ul><li>A meta-analysis investigated risk factors for non-alcoholic fatty liver disease. Data from 12 studies, with 22.8 million individuals followed up for a median of 10 years, demonstrated that type 2 diabetes mellitus was associated with a statistically significant, approximately 2-fold increased risk of incident severe liver disease events. Data from 14 studies with 19.3 million individuals followed up for a median of 13.8 years showed that obesity was associated with a 1.2-fold increased risk.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">Fargo, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">Jarvis, 2020</a>]</p><!-- end field 5360db4d-0f54-4fc0-9f24-55a1b7143a95 --><!-- end item 36bab86a-e0b4-4d47-ad90-4f2be2e8025d -->","subChapters":[]},{"id":"d0142bcc-a8ff-534b-97b7-979caf131690","slug":"autoimmune-liver-disorders","fullItemName":"Autoimmune liver disorders","depth":3,"htmlHeader":"<!-- begin field 1e98d87d-82c2-466d-b111-c7c1bb0fc2a4 --><h3>Autoimmune liver disorders</h3><!-- end field 1e98d87d-82c2-466d-b111-c7c1bb0fc2a4 -->","summary":null,"htmlStringContent":"<!-- begin item 2d3541a4-b69d-4ed8-9ff2-35f0ec2ec26b --><!-- begin field 322112f5-c48b-4eca-b5ae-c680f9b821bc --><ul><li><strong>Primary biliary cholangitis (previously primary biliary cirrhosis) (PBC)</strong><ul><li>PBC is a rare progressive liver disorder typically presenting in middle-aged women.</li><li>Symptoms include fatigue and itch. Jaundice develops as the disease progresses.</li><li>95% of people with PBC have high titres of anti-mitochondrial antibodies.</li></ul></li><li><strong>Primary sclerosing cholangitis (PSC)</strong><ul><li>PSC is a chronic progressive inflammatory condition that affects the intra- and extra-hepatic bile ducts leading to fibrosis and stricture formation.</li><li>PSC is more common in men. Nearly 70% of people with PSC also have inflammatory bowel disease and it can lead to cholangiocarcinoma.</li><li>Antinuclear cytoplasmic antibody is present in 30% of people with PSC.</li></ul></li><li><strong>Autoimmune hepatitis (AIH)</strong><ul><li>AIH is a chronic inflammatory liver disease that can lead to cirrhosis, liver failure, and death if untreated.</li><li>Most cases have no identifiable precipitant.</li><li>Prevalence ranges from 10–17 per 100,000 in Europe and women are affected 3–4 times more frequently than men.</li><li>AIH may present as an ‘acute hepatitis’ with jaundice preceded by anorexia, nausea, and flu-like symptoms, or more insidiously with fatigue, malaise, anorexia, and weight loss. Acute liver failure, nausea, amenorrhoea, and joint pains may also occur.</li><li>About 25% of people with AIH are asymptomatic at diagnosis.</li><li>Bloods tests may reveal raised serum aminotransferases (especially if alkaline phosphatase is normal), immunoglobulins, and autoantibodies (70% have smooth muscle antibody, 60% have antinuclear antibody) in the absence of viral hepatitis.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">Roche, 2004</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">Warrell, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">Gleeson, 2011</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">Fargo, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">BMJ Best Practice, 2019</a>]</p><!-- end field 322112f5-c48b-4eca-b5ae-c680f9b821bc --><!-- end item 2d3541a4-b69d-4ed8-9ff2-35f0ec2ec26b -->","subChapters":[]},{"id":"8bd0e8b7-5657-56be-a91d-0386f84b59ec","slug":"metabolic-causes","fullItemName":"Metabolic causes","depth":3,"htmlHeader":"<!-- begin field 7a80c1d6-76f8-49e4-b78a-1e17349cbcf3 --><h3>Metabolic causes of intra-hepatic jaundice</h3><!-- end field 7a80c1d6-76f8-49e4-b78a-1e17349cbcf3 -->","summary":null,"htmlStringContent":"<!-- begin item 1ebd3c0c-e344-49ea-a7fa-c89122966354 --><!-- begin field b777cb4d-ffcf-47f9-a841-f4a4f6328e6b --><ul><li><strong>Dubin-Johnson and Rotor’s syndromes</strong><ul><li>These are rare hereditary metabolic conditions that disrupt transport of conjugated bilirubin from the liver cells.</li></ul></li><li><strong>Haemochromatosis</strong><ul><li>Is the most common inherited liver disease in the UK, affecting 1 in 200 of the population.</li><li>It leads to iron overload, and people usually present with skin pigmentation (80%), cirrhosis (70%), or diabetes (55%) due to excessive iron deposits in the liver and pancreas.</li></ul></li><li><strong>Wilson’s disease </strong><ul><li>Is a rare autosomal recessive disorder that causes liver disease through excess deposition of copper in the hepatocytes. It also affects the basal ganglia and eyes.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">Ryder, 2001</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">Roche, 2004</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">BMJ Best Practice, 2019</a>]</p><!-- end field b777cb4d-ffcf-47f9-a841-f4a4f6328e6b --><!-- end item 1ebd3c0c-e344-49ea-a7fa-c89122966354 -->","subChapters":[]},{"id":"59ec9b70-fe11-5864-9100-56e7fddba723","slug":"malignancy-of-the-biliary-system","fullItemName":"Malignancy of the biliary system","depth":3,"htmlHeader":"<!-- begin field efaa6174-330b-4aa6-a430-f4d799a2ac00 --><h3>Malignancy of the biliary system</h3><!-- end field efaa6174-330b-4aa6-a430-f4d799a2ac00 -->","summary":null,"htmlStringContent":"<!-- begin item e814aeaf-78b4-4fdc-8216-094812d3eddc --><!-- begin field e82b2909-ed8d-4a11-9038-eaf19b0b8d9d --><ul><li>Biliary tract cancers are an uncommon but serious cause of jaundice.<ul><li><strong>Hepatocellular carcinoma</strong><ul><li>Hepatocellular carcinoma is the most common primary liver tumour worldwide.</li><li>Risk is increased in men, with advancing age, and in people with cirrhosis – especially due to hepatitis B and C infection.</li><li>Obesity, diabetes, alcohol use, and family history are also associated with increased risk.</li></ul></li><li><strong>Cholangiocarcinoma</strong><ul><li>Cholangiocarcinoma is the second most common primary liver tumour worldwide after hepatocellular carcinoma.</li><li>Primary sclerosing cholangitis is the most common known predisposing factor for cholangiocarcinoma in the Western world but most cases are sporadic.</li><li>Cholangiocarcinoma is usually advanced at presentation and typically presents with features of jaundice, pale stools, dark urine, itch, weight loss, and abdominal pain.</li></ul></li><li><strong>Gallbladder cancer</strong><ul><li>Gallbladder cancer typically presents with jaundice, hepatomegaly, and a mass in the right upper quadrant (Courvoisier's sign).</li></ul></li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">Ryder, 2003</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">Roche, 2004</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">Khan, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">BMJ Best Practice, 2019</a>]</p><!-- end field e82b2909-ed8d-4a11-9038-eaf19b0b8d9d --><!-- end item e814aeaf-78b4-4fdc-8216-094812d3eddc -->","subChapters":[]},{"id":"dcfd0474-123f-5899-8363-94f635536237","slug":"gallstones","fullItemName":"Gallstones","depth":3,"htmlHeader":"<!-- begin field a6af472c-48ab-4b98-a924-c1490f089bf6 --><h3>Gallstones</h3><!-- end field a6af472c-48ab-4b98-a924-c1490f089bf6 -->","summary":null,"htmlStringContent":"<!-- begin item 0ca01645-08b9-41b3-bfdd-932ba3fe0fa2 --><!-- begin field 502138e4-b05d-4c4c-b47f-64e3e174d79f --><ul><li>A gallstone (cholelithiasis) is a solid deposit that forms within the gallbladder or bile duct.</li><li>Prevalence varies between 5–25%, with a higher prevalence in women, those from Western countries, and with increasing age.</li><li>Most people with gallstone disease are asymptomatic but gallstones can cause obstruction of the flow of bile within the biliary duct system and lead to complications such as:<ul><li>Biliary colic — this describes pain in the epigastrium or right upper quadrant that is usually persistent, lasting from 15 minutes up to several hours. Pain lasting more than 24 hours or accompanied by fever suggests acute cholecystitis.</li><li>Nausea and vomiting.</li><li>Jaundice — this can occur when a gallstone causes obstruction within the biliary system.</li><li>Cholecystitis is inflammation or infection of the gallbladder with pain similar to biliary colic along with fever and tenderness in the right upper quadrant.</li><li>Cholangitis (inflammation or infection of the common bile duct) is classically diagnosed by the symptoms of Charcot’s triad fever, pain, and jaundice. It most often occurs because of an impacted gallstone and can be life-threatening.</li><li>Gallstone pancreatitis can present with sudden onset of pain in the epigastrium or left upper quadrant and may radiate into the back. Acute pancreatitis has a 3–20% mortality after a first acute attack.</li></ul></li><li>See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/gallstones/\">Gallstones</a> for further information.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">Roche, 2004</a>]  [<a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">Gurusamy, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">Fargo, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">BMJ Best Practice, 2019</a>]</p><!-- end field 502138e4-b05d-4c4c-b47f-64e3e174d79f --><!-- end item 0ca01645-08b9-41b3-bfdd-932ba3fe0fa2 -->","subChapters":[]},{"id":"d63993bd-fd65-53a6-9935-c9359f7fb327","slug":"surgical-strictures","fullItemName":"Surgical strictures","depth":3,"htmlHeader":"<!-- begin field 4f03459d-7012-47a0-81d9-b9eeaeeb029f --><h3>Surgical strictures</h3><!-- end field 4f03459d-7012-47a0-81d9-b9eeaeeb029f -->","summary":null,"htmlStringContent":"<!-- begin item a02d45fd-da9e-49c7-a754-6b990dfb82e0 --><!-- begin field a23d393d-f032-48c7-bb90-5977de358e3f --><ul><li>Biliary strictures and infection should be considered in people with post-operative jaundice.</li><li>Biliary strictures can occur following liver transplantation or cholecystectomy.</li><li>Complications associated with biliary strictures include chronic cholestasis, recurrent cholangitis, and secondary biliary cirrhosis.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">Roche, 2004</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">Deviere, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">BMJ Best Practice, 2019</a>]</p><!-- end field a23d393d-f032-48c7-bb90-5977de358e3f --><!-- end item a02d45fd-da9e-49c7-a754-6b990dfb82e0 -->","subChapters":[]},{"id":"9d2ec153-9bb9-5cb6-925f-4f03159b0203","slug":"extra-hepatic-malignancy","fullItemName":"Extra-hepatic malignancy","depth":3,"htmlHeader":"<!-- begin field e299a7dd-cb2c-4fad-819b-2b2f97034247 --><h3>Extra-hepatic malignancy</h3><!-- end field e299a7dd-cb2c-4fad-819b-2b2f97034247 -->","summary":null,"htmlStringContent":"<!-- begin item dbbad6df-9718-4dbc-8b93-e6545fb52883 --><!-- begin field b8faf07f-5a04-41bf-8176-04edc2dbe130 --><ul><li><strong>Pancreatic cancer</strong><ul><li>Pancreatic cancer can present with jaundice due to obstruction of the lower common bile duct.</li><li>In 2017, pancreatic cancer was the tenth most common cancer in the UK and the fifth most common cause of cancer death.</li><li>Incidence increases with age, in particular, over the age of 50 years.</li><li>Only 7% of people diagnosed with pancreatic cancer in England and Wales survive for 5 years or more.</li><li>A systematic review of eight studies with a collective total of 3,438,363 patients found that the only high-risk feature of pancreatic cancer in primary care was jaundice, with a positive predictive value of 4.1% in people aged over 40 years.</li><li>For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/gastrointestinal-tract-upper-cancers-recognition-referral/\">Gastrointestinal tract (upper) cancers - recognition and referral</a>.</li></ul></li><li><strong>Other extra-hepatic malignancies</strong><ul><li>Jaundice associated with lymphoma or metastatic cancers such as breast or bowel cancer can be due to intra-hepatic cholestasis from infiltration of the liver, or obstruction of the biliary ductal system.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">Schmidt-Hansen, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">BMJ Best Practice, 2019</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">CRUK, 2020</a>]</p><!-- end field b8faf07f-5a04-41bf-8176-04edc2dbe130 --><!-- end item dbbad6df-9718-4dbc-8b93-e6545fb52883 -->","subChapters":[]},{"id":"0c06ce08-0bab-5ece-b11e-a0d8e8cfc3aa","slug":"pancreatitis","fullItemName":"Pancreatitis","depth":3,"htmlHeader":"<!-- begin field 2bd16003-3cd6-4d6f-94ca-ebeeb102764c --><h3>Pancreatitis</h3><!-- end field 2bd16003-3cd6-4d6f-94ca-ebeeb102764c -->","summary":null,"htmlStringContent":"<!-- begin item 1f00fb2c-fafd-43f9-afaa-dbc1e40803aa --><!-- begin field 8e2ebeb8-7da9-4643-9f4d-ab35d9e9118b --><ul><li>Pancreatitis typically presents with sudden onset of severe pain in the epigastrium or left upper quadrant radiating into the back.</li><li>The most common causes of pancreatitis are alcohol misuse and gallstones.</li><li>Pancreatitis can lead to jaundice from pancreatic oedema.</li><li>For further information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/pancreatitis-acute/\">Pancreatitis - acute</a>.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">Roche, 2004</a>]</p><!-- end field 8e2ebeb8-7da9-4643-9f4d-ab35d9e9118b --><!-- end item 1f00fb2c-fafd-43f9-afaa-dbc1e40803aa -->","subChapters":[]},{"id":"6110c3ba-ff57-572a-b81d-41a69b1906db","slug":"parasitic-infection","fullItemName":"Parasitic infection","depth":3,"htmlHeader":"<!-- begin field 671bb541-b1d6-47a6-b7cf-d80ba858fca1 --><h3>Parasitic infection</h3><!-- end field 671bb541-b1d6-47a6-b7cf-d80ba858fca1 -->","summary":null,"htmlStringContent":"<!-- begin item 96f4c9d0-5805-4532-bd50-fa77e0cc86ca --><!-- begin field f9ef2b81-4c45-453d-95a9-f300461835a7 --><ul><li><em>Plasmodium falciparum</em> malaria causes jaundice in around 2.5% of affected people. Jaundice is usually caused by haemolysis of infected red blood cells, and less commonly by direct infection of hepatocytes.</li><li>In addition to malaria, infection with other parasites such as <em>Fasciola</em> and <em>Chlonorchis</em> can cause jaundice.<ul><li><strong><em>Fasciola</em></strong> is a liver fluke common in sheep and cattle in many areas of the world.<ul><li>Human infection occurs when <em>Fasciola</em> larvae are ingested in contaminated water or on water plants such as raw watercress.</li><li>After ingestion, the parasites migrate from the intestines to the liver and then settle in the bile ducts.</li><li>In the biliary system, the parasites can cause inflammation and blockage.</li></ul></li><li><strong><em>Chlonorchis</em></strong> is a liver fluke found across parts of Asia.<ul><li>Infection occurs when the larvae are ingested in raw or undercooked fish, crabs, or crayfish.</li><li>The juvenile parasites migrate from the duodenum to the biliary tract where they mature to adult flukes and can cause inflammation and intermittent obstruction.</li></ul></li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">BMJ Best Practice, 2019</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">CDC, 2019</a>]</p><!-- end field f9ef2b81-4c45-453d-95a9-f300461835a7 --><!-- end item 96f4c9d0-5805-4532-bd50-fa77e0cc86ca -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}